Exponent Inc (EXPO) Stock
Key stats
- Market cap
- $4.08B
- Price / Earnings ratio
- 37.2x
- EPS (TTM)
- $2.23
- Volume
- Loading
- 52-week high
- $88.17
- 52-week low
- $51.91
- Dividend yield
- 1.43%
- Dividend amount (latest)
- $0.31
Source: third-party data provider, as of November 7, 2026
Compare with EXPO
Recent news

What Exponent (EXPO) Said on Its Q3 Earnings Call
What Exponent (EXPO) Said on Its Q3 Earnings Call
EXPO

Exponent (EXPO) Tops Q3 Earnings and Revenue Estimates
Exponent (EXPO) Tops Q3 Earnings and Revenue Estimates
EXPO

Is Exponent (EXPO) Stock Outpacing Its Business Services Peers This Year?
Is Exponent (EXPO) Stock Outpacing Its Business Services Peers This Year?
EXPO

Are Business Services Stocks Lagging Exponent (EXPO) This Year?
Are Business Services Stocks Lagging Exponent (EXPO) This Year?
EXPO
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 76.89
- MACD 12/26/9
- 4.38
- EMA 9 of MACD
- 3.27
- MACD histogram
- 1.11
- SMA 50
- $71.48
- Price above SMA 50
- EMA 50
- $73.03
- Price above EMA 50
- SMA 200
- $66.81
- Price above SMA 200
- EMA 200
- $69.02
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

What Exponent (EXPO) Said on Its Q3 Earnings Call
What Exponent (EXPO) Said on Its Q3 Earnings Call
EXPO

Exponent (EXPO) Tops Q3 Earnings and Revenue Estimates
Exponent (EXPO) Tops Q3 Earnings and Revenue Estimates
EXPO

Is Exponent (EXPO) Stock Outpacing Its Business Services Peers This Year?
Is Exponent (EXPO) Stock Outpacing Its Business Services Peers This Year?
EXPO

Are Business Services Stocks Lagging Exponent (EXPO) This Year?
Are Business Services Stocks Lagging Exponent (EXPO) This Year?
EXPO

Wall Street Analysts Predict a 25.65% Upside in Exponent (EXPO): Here's What You Should Know
Wall Street Analysts Predict a 25.65% Upside in Exponent (EXPO): Here's What You Should Know
EXPO

Exponent Q2 Earnings Call Highlights
Exponent Q2 Earnings Call Highlights
EXPO

Exponent (EXPO) Surpasses Q2 Earnings and Revenue Estimates
Exponent (EXPO) Surpasses Q2 Earnings and Revenue Estimates
EXPO

Exponent (EXPO) Surpasses Q1 Earnings and Revenue Estimates
Exponent (EXPO) Surpasses Q1 Earnings and Revenue Estimates
EXPO

Exponent CEO Sells $529K in Stock as Company Eyes High Single-Digit Revenue Growth in 2026
Exponent CEO Sells $529K in Stock as Company Eyes High Single-Digit Revenue Growth in 2026
EXPO

3 Stocks to Consider From the Prospering Consulting Services Industry
3 Stocks to Consider From the Prospering Consulting Services Industry
EXPO
News tone: automated (AI) classification of the article's content, not a price prediction.
About Exponent Inc
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Catherine Ford Corrigan P.E., Ph.D. | CEO & Director | 1969 |
| Mr. Eric R. Anderson | Chief Financial Officer | 1975 |
| Mr. Richard L. Schlenker Jr. | Executive VP, Corporate Secretary & Director | 1966 |
| Dr. Maureen T. F. Reitman F.S.P.E., P.E., Sc.D. | Group Vice President | 1969 |
| Dr. Joseph Rakow Ph.D. | Group Vice President | 1977 |
| Dr. Joseph Sala Ph.D. | Group Vice President | 1977 |
| Dr. John D. Pye P.E., Ph.D. | President | 1971 |
| Dr. Bernard Ross P.E., Ph.D. | Co-Founder & Principal Engineer | — |
| Ms. Gina Flynn | VP of Legal & General Counsel | — |
| Mr. Brian Kundert | Chief Human Resources Officer | 1975 |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 7, 2026
Technical indicators
- RSI 14
- 76.89
- MACD 12/26/9
- 4.38
- EMA 9 of MACD
- 3.27
- MACD histogram
- 1.11
- SMA 50
- $71.48
- Price above SMA 50
- EMA 50
- $73.03
- Price above EMA 50
- SMA 200
- $66.81
- Price above SMA 200
- EMA 200
- $69.02
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst views
2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $82.00
- Average
- $91.00
- High
- $100.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -2.4 | +3.0 | ||||||||||
| 2022 | -18.8 | +0.3 | +14.5 | -11.6 | -3.6 | +2.4 | +9.7 | -3.7 | -4.8 | +6.2 | +6.3 | -3.7 |
| 2023 | +3.4 | -0.6 | -3.7 | -7.3 | -0.2 | +1.4 | -3.5 | +1.8 | -5.3 | -14.0 | +8.8 | +11.3 |
| 2024 | -3.0 | -10.1 | +2.4 | +13.3 | +3.6 | +0.6 | +6.1 | |||||
| 2026 | +5.9 | -11.6 | +2.9 | -10.7 | -2.7 | +11.5 | +4.0 | -6.9 | +14.8 | -0.9 |




